Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Conflicting Analyst Opinions on Aris Water Solutions Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_Credit
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Wells Fargo analyst Praneeth Satish upgraded Aris Water Solutions to an Equal-Weight rating and increased the price target to $11.

__________

However, there are conflicting opinions among analysts regarding the price target for Aris Water Solutions. J.P. Morgan set a target of $14.00, Stifel Nicolaus at $17.00, and Citi at $13.00. The consensus rating for Aris Water Solutions is a Moderate Buy based on the assessments of 2 Wall Street analysts.

__________

The average twelve-month price forecast for Aris Water Solutions stands at $13.86, with a high target of $20.00 and a low of $9.00. Analysts predict a mean target price of $14.18, indicating a potential upside of 16.44%.

__________

In addition, Evercore ISI adjusted the price target for Aris Water Solutions to $20 from $24 while maintaining an Outperform rating.

ARIS Stock Update: March 7, 2024 – Potential for Future Growth

On March 7, 2024, ARIS stock closed at $11.48, a decrease of $0.26 or 2.21% from the previous market close. In after-hours trading, the stock dropped another $0.26. Despite this decline, ARIS is still trading in the middle of its 52-week range and above its 200-day simple moving average, indicating relative stability over the long term. Investors may be watching closely to see if the stock can rebound from this drop and should monitor any upcoming news or developments that could impact its performance. Overall, while ARIS experienced a setback on March 7, its position within its 52-week range and above its 200-day moving average suggest potential for future growth. Investors should stay informed about any relevant market news.

ARIS Stock Reports Strong Growth in Revenue and Net Income for the Past Year, Flat Performance in Fourth Quarter

On March 7, 2024, ARIS stock had a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, ARIS reported a total revenue of $392.12 million for the past year, which represents a 22.15% increase compared to the previous year. However, the total revenue remained flat compared to the previous quarter, with the company reporting $104.12 million in revenue for the fourth quarter.

In terms of net income, ARIS reported a net income of $18.89 million for the past year, which marks a significant increase of 1011.06% compared to the previous year. Similar to the total revenue, the net income held flat since the previous quarter, with the company reporting $5.40 million in net income for the fourth quarter.

Earnings per share (EPS) also showed a significant increase for ARIS, with the company reporting an EPS of $0.59 for the past year, representing a staggering 1306.43% increase compared to the previous year. However, similar to the total revenue and net income, the EPS held flat since the previous quarter, with the company reporting an EPS of $0.17 for the fourth quarter.

Overall, ARIS stock showed strong growth in terms of total revenue, net income, and EPS compared to the previous year. However, the performance remained flat since the previous quarter, which may have impacted the stock performance on March 7, 2024. Investors will be closely monitoring the company’s future financial results to assess its growth potential and stock performance in the coming quarters.

Tags: ARIS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
SO stock news

Analyst Edward Kelly Maintains Underweight Rating on United Natural Foods Lowers Price Target

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

DrugRetailers Trading online

Arhaus Reports Surprising Quarterly Earnings Beat

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com